Krka, d. d., Novo mesto (KRK) Stock Price & Analysis
KRK Stock Chart & Stats
- Day’s Range
- PLN 1,104.00 - PLN 1,116.00
- 52-Week Range
- PLN 810.00 - PLN 1,200.00
- Previous Close
- PLN 1,114.00
- Volume
- N/A
- Average Volume (3M)
- 51
- Market Cap
- PLN 34.79B
- Enterprise Value
- PLN 29.64B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 18.5
- Beta
- 0.17
- Next Earnings
- Dec 11, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 21, 2026
- Dividend Yield
- 3.59%
KRK FAQ
What was Krka, d. d., Novo mesto’s price range in the past 12 months?
What is Krka, d. d., Novo mesto’s market cap?
When is Krka, d. d., Novo mesto’s upcoming earnings report date?
How were Krka, d. d., Novo mesto’s earnings last quarter?
Is Krka, d. d., Novo mesto overvalued?
Does Krka, d. d., Novo mesto pay dividends?
What is Krka, d. d., Novo mesto’s EPS estimate?
How many shares outstanding does Krka, d. d., Novo mesto have?
What happened to Krka, d. d., Novo mesto’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Krka, d. d., Novo mesto?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Krka, d. d., Novo mesto
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jože Colarič
- Employees
- 13,236
- Website
- www.krka.biz
- Address
- Šmarješka cesta 6, Novo Mesto, NM, 8501, SI
Krka, d. d., Novo mesto (KRK) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 4 | 11 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 3 | 0 | 9 |
